STRATTAN CE RICK - Insider Non-Derivative Transactions at Cyclo Therapeutics, Inc. (CYTH) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 27, 2025, STRATTAN CE RICK's relationship to Cyclo Therapeutics, Inc. (CYTH) is Director, and currently has 399,272 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CYTH insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
STRATTAN CE RICK - Insider Non-Derivative Transactions of CYTH Common Stock
STRATTAN CE RICK - Insider Non-Derivative Transactions at CYTH
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 28, 2025 Acquisition -- (Common Stock) 30169 0 399272
Nov 16, 2024 Acquisition -- (Common Stock) 63608 0 369103
Aug 17, 2024 Acquisition -- (Common Stock) 9524 0 305495
Jun 4, 2024 Acquisition -- (Common Stock) 9375 0 295971
Feb 14, 2024 Acquisition -- (Common Stock) 6963 0 286596
Nov 29, 2023 Acquisition -- (Common Stock) 8209 0 279633
Oct 28, 2023 Acquisition -- (Common Stock) 42599 0 271424
Aug 19, 2023 Acquisition -- (Common Stock) 8089 0 228825
May 18, 2023 Acquisition -- (Common Stock) 21360 0 220736